Somerville Kurt F Laboratory Corp Of America Holdings Transaction History

Somerville Kurt F

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$204.81 - $262.19 $24,577 - $31,462	-120 Reduced 5.41%	2,100 $430,000
Q1 2019 May 01, 2019	SELL	$123.7 - $156.3 $3,092 - $3,907	-25 Reduced 1.11%	2,220 $340,000
Q3 2018 Oct 15, 2018	SELL	$167.67 - $188.27 $2,515 - $2,824	-15 Reduced 0.66%	2,245 $390,000
Q1 2018 Apr 24, 2018	SELL	$161.53 - $178.11 $161,530 - $178,110	-1,000 Reduced 30.67%	2,260 $365,000
Q4 2017 Feb 02, 2018	SELL	$147.99 - $163.95 $73,995 - $81,975	-500 Reduced 13.3%	3,260 $520,000
Q3 2017 Oct 26, 2017	BUY	$149.47 - $160.56 $562,007 - $603,705	3,760	3,760 $567,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

Stay updated on Somerville Kurt F with notifications on news.